AU777218B2 - Staphyloccocus aureus antigen-containing whole cell vaccine - Google Patents
Staphyloccocus aureus antigen-containing whole cell vaccine Download PDFInfo
- Publication number
- AU777218B2 AU777218B2 AU49950/00A AU4995000A AU777218B2 AU 777218 B2 AU777218 B2 AU 777218B2 AU 49950/00 A AU49950/00 A AU 49950/00A AU 4995000 A AU4995000 A AU 4995000A AU 777218 B2 AU777218 B2 AU 777218B2
- Authority
- AU
- Australia
- Prior art keywords
- antigen
- staphylococcus aureus
- cell
- type
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/307775 | 1999-05-10 | ||
US09/307,775 US6294177B1 (en) | 1996-09-11 | 1999-05-10 | Staphylococcus aureus antigen-containing whole cell vaccine |
PCT/US2000/012589 WO2000067785A2 (fr) | 1999-05-10 | 2000-05-10 | Vaccin a cellules entieres contenant l'antigene de staphylococus aureus |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4995000A AU4995000A (en) | 2000-11-21 |
AU777218B2 true AU777218B2 (en) | 2004-10-07 |
Family
ID=23191126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU49950/00A Ceased AU777218B2 (en) | 1999-05-10 | 2000-05-10 | Staphyloccocus aureus antigen-containing whole cell vaccine |
Country Status (15)
Country | Link |
---|---|
US (2) | US6294177B1 (fr) |
EP (1) | EP1178824B1 (fr) |
JP (1) | JP2002544169A (fr) |
AT (1) | ATE337015T1 (fr) |
AU (1) | AU777218B2 (fr) |
BR (1) | BR0010478A (fr) |
CA (1) | CA2372633C (fr) |
CY (1) | CY1105744T1 (fr) |
DE (1) | DE60030274T2 (fr) |
DK (1) | DK1178824T3 (fr) |
ES (1) | ES2270835T3 (fr) |
MX (1) | MXPA01011507A (fr) |
NZ (1) | NZ515394A (fr) |
PT (1) | PT1178824E (fr) |
WO (1) | WO2000067785A2 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610293B1 (en) * | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US6936258B1 (en) * | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
US6974573B2 (en) * | 1999-11-01 | 2005-12-13 | Mucovax Holdings, B.V. | Antibody production in farm animals |
US20030096315A1 (en) | 2000-05-03 | 2003-05-22 | Sanders Mitchell C. | Device for detecting bacterial contamination and method of use |
MXPA03011701A (es) * | 2001-06-15 | 2004-12-06 | Nhibitex Inc | Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus. |
CA2474458A1 (fr) * | 2002-01-31 | 2003-08-07 | Mitchell C. Sanders | Methode de detection de micro-organismes |
JP4304077B2 (ja) * | 2002-02-13 | 2009-07-29 | イミュノロジー ラボラトリーズ インコーポレイテッド | 微生物感染の処置のための組成物および方法 |
US6984381B2 (en) | 2002-07-05 | 2006-01-10 | The United States Of America As Represented By The Secretary Of Agriculture | Vaccine for the prevention of bacterial infection of the bovine mammary gland |
PL229487B1 (pl) * | 2002-11-12 | 2018-07-31 | Brigham & Womens Hospital Inc | Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego |
KR101359930B1 (ko) | 2004-09-22 | 2014-02-12 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스태필로코쿠스에 대한 예방접종에 사용하기 위한 면역원성조성물 |
KR20070104590A (ko) * | 2005-01-10 | 2007-10-26 | 나비 바이오파마슈티컬즈 | 스타필로코쿠스 아우레우스 감염을 치료하는 방법 |
US20060228368A1 (en) * | 2005-04-07 | 2006-10-12 | Nabi Biopharmaceuticals | Method of protecting against staphylococcal infection |
WO2006135912A2 (fr) | 2005-06-13 | 2006-12-21 | Nabi Biopharmaceuticals | Utilisation de leucocidine de panton valentine pour le traitement et la prevention d'infections causees par le staphylococcus |
SG170090A1 (en) * | 2006-03-30 | 2011-04-29 | Glaxosmithkline Biolog Sa | Immunogenic composition |
CA2655133C (fr) | 2006-06-12 | 2018-03-20 | Nabi Biopharmaceuticals | Utilisation de toxine alpha pour le traitement et la prevention d'infections par le staphylocoque |
US20080170996A1 (en) * | 2006-07-28 | 2008-07-17 | The Board Of Regents Of The University Of Texas System | Compositions and Methods for Stimulation of Lung Innate Immunity |
EP2161035B1 (fr) * | 2007-05-28 | 2019-08-21 | Daiichi Sankyo Company, Limited | Composition de vaccin à cellules entières contenant bordetella parapertussis |
EP2175880A1 (fr) * | 2007-07-23 | 2010-04-21 | Vaccine Research International PLC | Vaccin à cellules entières staphylococciques inactivées |
JP5658564B2 (ja) * | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
CA2731384C (fr) | 2008-07-21 | 2015-03-10 | The Brigham And Women's Hospital, Inc. | Procedes et compositions se rapportant a des beta-1,6-glucosamine oligosaccharides synthetiques |
US8758765B2 (en) * | 2008-07-29 | 2014-06-24 | The University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
US20110105383A1 (en) * | 2008-09-10 | 2011-05-05 | Magnus Hook | Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
BRPI0920041A2 (pt) | 2008-10-06 | 2017-06-27 | Univ Chicago | composições e processos relacionados às proteínas eap, emp e/ou adsa bacterianas |
US20100150942A1 (en) * | 2008-12-03 | 2010-06-17 | Cantor Thomas L | Affinity purified human polyclonal antibodies and methods of making and using them |
MX2011010050A (es) | 2009-03-25 | 2011-12-14 | Univ Texas | Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos. |
BRPI1010307B1 (pt) | 2009-04-03 | 2021-07-27 | University Of Chicago | Polipeptídeos variantes de proteína a (spa), composição imunogênica compreendendo os mesmos, vacina, método de produção da referida vacina, bem como uso dos referidos polipeptídeos |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
CN102971009A (zh) | 2009-10-30 | 2013-03-13 | 诺华有限公司 | 金黄色葡萄球菌5型和8型荚膜多糖的纯化 |
JP2013523818A (ja) | 2010-04-05 | 2013-06-17 | ザ・ユニバーシティー・オブ・シカゴ | 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法 |
ES2655701T3 (es) | 2010-07-02 | 2018-02-21 | The University Of Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SpA) |
US9095540B2 (en) | 2010-09-09 | 2015-08-04 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
CN104768572B (zh) | 2012-04-26 | 2021-08-24 | 芝加哥大学 | 葡萄球菌凝固酶抗原及其使用方法 |
GB201310008D0 (en) | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
WO2016044839A2 (fr) | 2014-09-19 | 2016-03-24 | The Board Of Regents Of The University Of Texas System | Compositions et méthodes pour traiter des infections virales par le biais de l'immunité innée stimulée en combinaison avec des composés antiviraux |
EP3229833A1 (fr) | 2014-12-10 | 2017-10-18 | GlaxoSmithKline Biologicals SA | Procédé de traitement |
US11053532B2 (en) | 2017-04-19 | 2021-07-06 | CAP Diagnostics, LLC | Methods for treating polymicrobial infections |
WO2019055620A1 (fr) * | 2017-09-13 | 2019-03-21 | Stc. Unm | Répliques de cellule silicifiées, procédés de fabrication et procédés d'utilisation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998010788A1 (fr) * | 1996-09-11 | 1998-03-19 | Nabi | ANTIGENE DE $i(STAPHYLOCOCCUS AUREUS) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3345864A1 (de) | 1983-12-19 | 1985-06-27 | Egbert Frh. von 8000 München Malsen-Ponickau | Impfstoff und verfahren zu seiner herstellung |
NZ216119A (en) | 1985-05-13 | 1989-01-06 | Commw Scient Ind Res Org | Vaccine produced using antigens of a pseudocapsule producing strain of s.aureus |
US5571511A (en) * | 1990-10-22 | 1996-11-05 | The U.S. Government | Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
-
1999
- 1999-05-10 US US09/307,775 patent/US6294177B1/en not_active Expired - Lifetime
-
2000
- 2000-05-10 ES ES00932194T patent/ES2270835T3/es not_active Expired - Lifetime
- 2000-05-10 JP JP2000616810A patent/JP2002544169A/ja active Pending
- 2000-05-10 CA CA2372633A patent/CA2372633C/fr not_active Expired - Fee Related
- 2000-05-10 NZ NZ515394A patent/NZ515394A/en not_active IP Right Cessation
- 2000-05-10 WO PCT/US2000/012589 patent/WO2000067785A2/fr active IP Right Grant
- 2000-05-10 DE DE60030274T patent/DE60030274T2/de not_active Expired - Lifetime
- 2000-05-10 EP EP00932194A patent/EP1178824B1/fr not_active Expired - Lifetime
- 2000-05-10 AT AT00932194T patent/ATE337015T1/de active
- 2000-05-10 PT PT00932194T patent/PT1178824E/pt unknown
- 2000-05-10 BR BR0010478-7A patent/BR0010478A/pt active Search and Examination
- 2000-05-10 AU AU49950/00A patent/AU777218B2/en not_active Ceased
- 2000-05-10 MX MXPA01011507A patent/MXPA01011507A/es active IP Right Grant
- 2000-05-10 DK DK00932194T patent/DK1178824T3/da active
-
2001
- 2001-09-24 US US09/961,110 patent/US6537559B2/en not_active Expired - Fee Related
-
2006
- 2006-11-01 CY CY20061101563T patent/CY1105744T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998010788A1 (fr) * | 1996-09-11 | 1998-03-19 | Nabi | ANTIGENE DE $i(STAPHYLOCOCCUS AUREUS) |
Also Published As
Publication number | Publication date |
---|---|
US6294177B1 (en) | 2001-09-25 |
ES2270835T3 (es) | 2007-04-16 |
AU4995000A (en) | 2000-11-21 |
CA2372633A1 (fr) | 2000-11-16 |
CY1105744T1 (el) | 2010-12-22 |
MXPA01011507A (es) | 2002-11-07 |
PT1178824E (pt) | 2007-01-31 |
EP1178824B1 (fr) | 2006-08-23 |
US20020031528A1 (en) | 2002-03-14 |
US6537559B2 (en) | 2003-03-25 |
WO2000067785A2 (fr) | 2000-11-16 |
DE60030274D1 (de) | 2006-10-05 |
WO2000067785A3 (fr) | 2001-02-08 |
JP2002544169A (ja) | 2002-12-24 |
NZ515394A (en) | 2004-11-26 |
ATE337015T1 (de) | 2006-09-15 |
DK1178824T3 (da) | 2006-10-09 |
CA2372633C (fr) | 2010-03-30 |
EP1178824A2 (fr) | 2002-02-13 |
DE60030274T2 (de) | 2008-01-10 |
BR0010478A (pt) | 2002-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU777218B2 (en) | Staphyloccocus aureus antigen-containing whole cell vaccine | |
US6194161B1 (en) | Staphylococcus aureus antigen | |
CA2366433C (fr) | Antigene et vaccin de staphylocoque | |
AU754890B2 (en) | Enterococcus antigens and vaccines | |
MXPA00003674A (en) | Enterococcus antigens and vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TC | Change of applicant's name (sec. 104) |
Owner name: NABI BIOPHARMACEUTICALS Free format text: FORMER NAME: NABI |